This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street
Terns Pharmaceuticals is a small-cap biotech with a couple of weight loss candidates in its pipeline. The stock's price ...
Weight-loss drug battle: Who are the latest players involved
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
BioSpace17d
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
“The unique pharmaceutical properties of TERN-601 allowed for rapid titration in our 28-day Phase 1 study, resulting in competitive weight loss without dose interruptions, reductions, or ...
Investing17d
Terns Pharmaceuticals reports progress in clinical trials
Terns plans to publish these DDI results at a future scientific conference. In the field of obesity treatment, Terns unveiled the design for the Phase 2 FALCON trial of TERN-601, a small-molecule ...
Morningstar17d
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
“The unique pharmaceutical properties of TERN-601 allowed for rapid titration in our 28-day Phase 1 study, resulting in competitive weight loss without dose interruptions, reductions, or ...